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Abstract: The importance of CD45RB expres-
sion on T cells was already shown in mice where
CD45RBhigh expression determines pathogenic po-
tential. In this study, we analyzed the expression of
CD45RA, CD45RB, and CD45RO on CD4 T
lymphocytes in the intestinal mucosa and in the
circulation of patients with inflammatory bowel dis-
ease (IBD). In addition, we studied the cytokine
profile of these cells. In the circulation, virtually all
CD4CD45RBhigh T cells expressed the naive
marker CD45RA, and circulating CD4CD45RBlow
cells expressed the memory marker CD45RO in IBD
patients and a control patient population. In contrast,
the intestinal CD4 CD45RBhigh T cells are in nor-
mal controls for 90% CD45RO. However, in IBD,
27.7% [Crohn’s disease (CD)] and 49% [ulcerative
colitis (UC)] of the intestinal CD4 CD45RBhigh T
cells are CD45RA. This special CD4CD45RA T
cell in IBD can be found in the lamina propria as well
as in lymphoid follicles (confocal laser-scanning mi-
croscopy). The CD4CD45RBhigh T lymphocytes
produce significantly less interleukin (IL)-10 and
IL-4 and produce more tumor necrosis factor  than
CD45RBlow T lymphocytes in control patients.
CD4CD45RBlow T cells from IBD patients pro-
duced less IL-10 than CD4CD45RBlow T lympho-
cytes of controls, and interferon- production by
both T lymphocyte subsets was decreased in IBD.
These data indicate that CD and UC are character-
ized by an influx of CD4CD45RBhigh T lympho-
cytes. These CD4CD45RBhigh T lymphocytes
seem to be important in the pathogenesis of IBD, as
they produce more proinflammatory cytokines and
less anti-inflammatory cytokines compared with
CD4CD45RBlow T lymphocytes. J. Leukoc. Biol.
75: 1010–1015; 2004.
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INTRODUCTION
Crohn’s disease (CD) and ulcerative colitis (UC) are complex,
multifactorial human inflammatory bowel diseases of which the
etiology remains poorly understood. Recently, a genetic defect
in the gene encoding a protein involved in the recognition of
microbes, NOD2, was identified [1]. This links a dysregulated
immune response to enteric bacteria to disease development in
the immune susceptible host. Pathogenic CD4 T lymphocytes
are believed to play a major role in the pathogenesis of inflam-
matory bowel disease (IBD).
To study the mechanism of disease development, several
mouse models of experimentally induced or spontaneously
occurring colitis are available (for review, see ref. [2]). One of
these models involves the adoptive transfer of a pathogenic
CD4CD45RBhigh T cell subpopulation into an immuno-defi-
cient recipient. Transfer of CD4CD45RBhigh T cells from
donor mice into genetically immuno-deficient (recombination
activating gene-2/) mice or severe combined immunodefi-
ciency mice results in a spontaneous chronic and severe in-
flammation of the large intestines [3]. In contrast, cotransfer of
the CD4CD45RBlow T cell subset protects against disease [4]
or results in a later onset of disease [5].
The level of expression of CD45RB on mouse CD4 T cells
is believed to distinguish naı¨ve (CD45RBhigh) from activated/
memory (CD45RBlow) cells [6].
In humans, two other isoforms of CD45, CD45RA and
CD45RO, are used to distinguish naı¨ve and primed/memory T
cells, respectively [7, 8]. However, there is also a reverse
CD45RB expression on CD45RA and CD45RO cells in human
peripheral blood [9]. In the peripheral blood, CD45RA-positive
T cells express high levels of CD45RB, whereas CD45RO cells
express little CD45RB. Hitherto, the role of CD45RB expres-
sion in human intestinal inflammation has not been evaluated
in detail.
The expression of CD45 is essential for the activation of T
lymphocytes via the T cell receptor. The intracellular domain
of CD45 contains a protein tyrosine phosphatase that regulates
the intracellular proteins p56lck and p59fyn on T cell activation
[10]. T lymphocytes express different isoforms of the extracel-
lular domain of CD45 [7]. The expression of the isoforms varies
between subpopulations of T lymphocytes and changes upon
stimulation and differentiation. The CD45 isoforms display
different abilities to support T cell activation [11].
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Conflicting reports exist concerning the distribution of mem-
ory and naı¨ve cells in the peripheral blood cells of IBD
patients. The number of memory cells was reported to be
elevated in the peripheral blood of CD patients [12], but these
observations were not confirmed in another report [13]. In the
mucosa of the gut, almost all CD4-positive cells express the
CD45RO marker and are therefore considered memory cells.
In view of the functional differences of T lymphocytes that
express the various CD45 isoforms, we investigated the expres-
sion of CD45RA, CD45RO, and CD45RB by peripheral- and
gut-derived T lymphocytes from IBD patients and controls. To
further study the functional difference between CD45RBhigh
and CD45RBlow cells, peripheral- and gut-derived T lympho-
cytes were sorted and stimulated with CD3/CD28. The pro- and




Mucosal lymphocytes were isolated from surgical resection specimens from
patients with active CD or UC who underwent partial resection of the intes-
tines. Eight CD patients (two male and six female) with a mean age of 34.8
years (range, 27–44 years) and median disease duration of 6.25 years (range,
1–12 years) were included. Four patients had ileal disease, and four had
colonic disease. All patients were on corticosteroids. The mean age of the eight
UC patients (four males and four females) was 34.8 years (range, 22–48 years),
and mean disease duration was 4 years (range, 1–9 years). Six of these patients
were on corticosteroids. Control mucosal lymphocytes were obtained from six
patients undergoing a resection for cancer (three males and three females).
Mean age of this group was 61.8 (range, 40–78 years). The disease was located
in the rectum (two) and in the colon (four), and noninvolved bowel segments
were used for this study.
Cell preparation of mucosal specimen
Freshly obtained mucosal specimens (3 cm0.5 cm) were homogenized using
an automated, mechanical tissue desecration device (Medimachine system,
Dako, Danmark). Cell suspensions were centrifuged with Ficoll (Pharmacia,
Uppsala, Sweden), and the mononuclear cells were subsequently passed
through a 40-M filter cell strainer (Becton Dickinson Transduction Labora-
tories, Franklin Lakes, NJ). Subsequently, cells were washed with fluores-
cence-activated cell sorter buffer (phosphate-buffered saline, containing 0.5%
bovine serum albumin, 0.3 mmol/L EDTA, and 0.01% sodium azide) and were
kept on ice for the rest of the procedure.
Flow cytometry
Four color FACSCalibur analysis was used to determine the expression of
CD45RA and CD45RO within the CD45RBhigh and CD45RBlow subgroups.
One million cells per well (96-well microplate, Greiner B.V. Labor Techniek,
Alphen aan de Rijn, The Netherlands) were incubated with anti-CB45RB
(Southern Biotechnology Associates, Birmingham, AL) and anti-immunoglob-
ulin G–peridinin chlorophyll protein (Per CP) as secondary antibody. Subse-
quently, cells were incubated with anti-CD4–allophycocyanin (APC)-, anti-
CD45RO–phycoerythrin (PE)-, and anti-CD45RA–fluorescein isothiocyanate
(FITC)-labeled antibody (Immunotech, Marseille, France). Isotype controls
were used to determine the negative gates.
Analysis was done on a FACSCalibur in conjunction with the Cellquest Pro
(BD Biosciences, Pharmingen, San Diego, CA) software, and 5000 cells were
counted. CD4CD45RBhigh and CD4CD45RBlow subsets were defined as
40% of the highest and 40% of the lowest CD4CD45RB-expressing cells.
Sorting of peripheral blood mononuclear cells
(PBMC) and gut-derived T cells
Blood was drawn into a tube containing heparin (final concentration, 10 U/ml).
PBMC were obtained using Ficoll-Hypaque (Sigma Chemical Co., St. Louis,
MO) density gradient centrifugation (400 g, 20 min). Subsequently, the cells
residing at the interface were washed three times and resuspended in Iscove’s
medium supplemented with 10% pooled human serum (BioWhittaker, Bel-
gium) and ciproxin (10 g/ml; Gibco-BRL, Life Technologies, Rockville, MD).
Gut-derived T cells were isolated as described above under sterile conditions
and resuspended in Iscove’s medium supplemented with 10% pooled human
serum and ciproxin. For staining, per 1  107 cells, 20 l unlabeled mouse
anti-human-CD45RB antibody was added, and cells were incubated for 30 min
on ice. After washing with sterile medium [Iscove’s medium supplemented with
10% pooled human serum (BioWhittaker)] and ciproxin (10 g/ml), a second-
ary goat anti-mouse–FITC-labeled antibody (Immunotech) was added and
incubated for 20 min on ice in the dark. Subsequently, cells were washed, and
a 10-min blocking step with normal mouse serum (CLB, Amsterdam, The
Netherlands) without preservative was performed before staining with 10 l
mouse anti-human–CD4–PE–Cy5-labeled antibody (Immunotech) per 1 107
cells for 20 min on ice in the dark. Cells were sorted by use of the FACS-
Vantage (BD Biosciences, Pharmingen) under sterile conditions.
CD4CD45RBhigh and CD4CD45RBlow subsets were sorted and defined as
40% of the highest and 40% of the lowest CD4CD45RB-expressing cells.
After sorting, the subpopulations were reanalyzed on a FACScan or FACS-
Calibur (BD Biosciences, PharMingen), and only the populations more than
95% pure were used. The sorted cells were washed and resuspended in RPMI
1640 (BioWhittaker), supplemented with 5% pooled human serum (BioWhit-
taker) and antibiotics (Gibco-BRL, Life Technologies). Sorted cells were
stimulated (concentration, 1105/well) with anti-human anti-CD3 and anti-
CD28 antibodies (both 1:1000, CLB) for 72 h at 37°C.
Cytokines
Supernatant of the stimulated peripheral blood cells was aspirated, and the
concentration of interleukin (IL)-4, IL-10, interferon- (IFN-), and tumor
necrosis factor  (TNF-) was analyzed using enzyme-linked immunosorbent
assay (CLB), according to the instruction of the manufacturer. For cytokine
determination in the supernatants of the stimulated gut-derived T cells, the
Cytometric Bead Array kit (BD Biosciences, PharMingen) was used, according
to the manufacturer’s instructions.
Immunofluorescence staining
Double-staining was performed as described previously with some modifica-
tions [14]. Briefly, cryostat fragments of colon tissue were cut into 4–6 m
sections, air-dried overnight, and fixed in acetone for 10 min at room temper-
ature. The slides were first incubated with 5% (vol/vol) normal goat serum
(CLB), then with optimal dilutions of CD45RA–FITC (BD Biosciences, Phar-
Mingen), CD4–PE (BD Biosciences, PharMingen), rabbit anti-PE (Biogenesis,
UK), and Cy3-conjugated goat anti-rabbit (Jackson Immunoresearch Labora-
tories, West Grove, PA). For each fluorochrome label, negative-control anti-
bodies were included. Fluoresence was analyzed using a Leica TCS SP (Leica
Microsystems, Heidelberg, Germany) confocal system, equipped with an Ar/Kr
laser combination.
Statistics
Data are provided as mean and SEM. The Mann-Whitney U-test and the
Wilcoxon test were used where appropriate (SPSS for Windows, version 7.5).
A double-sided P  0.05 was considered to represent a significant difference.
RESULTS
Differential expression of CD45RA and CD45RO
within the mucosal CD4CD45RBhigh T cell
subpopulation
To examine the distribution of naı¨ve (CD45RA) and memory
cells (CD45RO) within the CD45RBhigh and the CD45RBlow
subgroups, four-color flowcytometric analysis was performed
on peripheral blood and mucosal lymphocytes of controls, CD,
and UC patients (Fig. 1A). In peripheral blood of controls,
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99.6  0.4% of the CD45RBhigh cells were CD45RA,
whereas the CD45RBlow subgroup almost exclusively con-
tained CD45RO cells (93.41.2%). No differences were ob-
served among UC, CD, and controls (Table 1).
Within the gut mucosa, the number of CD4CD45RBhigh T
cells in IBD is significantly increased compared with controls
(Fig. 1B). In controls, 2.5  1.2% of the CD4 T cells are
CD45RBhigh compared with 18 5% in CD and 41 9.3% in
UC. Also, the distribution of CD45RO and CD45RA within the
CD45RBhigh and CD45RBlow CD4 populations differed from
peripheral blood (Fig. 1C). The CD4CD45RBlow cells from
the gut, in contrast, were almost exclusively CD45RO-postive,
and no differences were seen among CD, UC, or normal,
control, gut-derived T cells (Table 1). However, within the
CD4CD45RBhigh subpopulation of gut-derived CD4 T cells,
CD45RA-positive and CD45RO-positive cells were found (Ta-
ble 1). In CD patients, the CD45RA/RO ratio was 27.7/59.7
and in UC, 49.0/34.8, compared with 4.5/90.0 in controls. This
indicates that in IBD, the majority of the gut-derived CD4 T
cells is in fact CD45RBhigh CD45RA.
To determine the localization of these CD4/CD45RA cells
in the intestinal mucosa, cryostat sections of IBD patients were
stained for CD45RA and prepared for confocal laser-scanning
microscopy (Fig. 2). In IBD patients, CD45RA-positive cells
were found in the lamina propria and in follicular structures.
Cytokine profile of CD45RB cells in peripheral
blood cells
To investigate functional differences between the
CD4CD45RBhigh and CD4CD45RBlow T cell subsets,
PBMC were sorted for the expression of this marker. After
sorting, cells were stimulated for 72 h by anti-CD3/anti-CD28
double-stimulation, and the production of IFN-, IL-10,
TNF-, and IL-4 was determined (Fig. 3). CD4CD45RBlow T
cells of normal controls produced fivefold more IL-10 than
CD4CD45RBhigh T cells (330.5 pg/ml42.1 and 65.9 pg/
ml29.1, respectively). Furthermore, IL-4 production was sig-
nificantly increased in CD4CD45RBlow T cells (952.7 pg/
ml187.8 vs. 226.4 pg/ml65.9 in CD4CD45RBhigh T
cells). In contrast, CD4CD45RBhigh T cells produced more
TNF- (1122.3 pg/ml198.1 and 2617.9 pg/ml482.6). Both
CD45RB subpopulations produced large amounts of IFN-
(P	0.064; 6718.0 pg/ml1761.3 and 11981.6 pg/
ml3439.4).
Stimulated CD4CD45RBlow T cells of CD and UC patients
produced significantly less IL-10 than cells isolated from nor-
mal controls (200.6 pg/ml58.6 in CD patients and 147.9
pg/ml93.9 in UC patients compared with 330.5 pg/ml42.1
in controls). IFN- production of peripheral blood
CD4CD45RBhigh and CD4CD45RBlow T cells was signifi-
Fig. 1. Distribution of CD45RA and CD45RO within
CD45RBhigh and CD45RBlow subpopulations in the gut
mucosa and peripheral blood. (A) Expression of CD45RO
(x-axis) and CD45RA (y-axis) in CD4 peripheral blood
lymphocytes in CD45RBlow (left) and CD45RBhigh (right)
cells in control, UC, and CD. (B) CD45RB and CD4
expression on gut-derived lymphocytes in control, UC,
and CD. (C) Expression of CD45RO (x-axis) and CD45RA
(y-axis) in CD4 gut-derived lymphocytes in CD45RBlow
(left) and CD45RBhigh (right) cells in control, UC, and
CD.
TABLE 1. CD45RA, CD45RB, and CD45RO Expression on Gut- and Peripheral Blood Derived CD4 T Lymphocytes
in UC or CD and Control Patients
CD4 lymphocytes CD45RBlow CD45RO CD45RBhigh CD45RA CD45RBhigh CD45RO
Control Gut-derived 98.1  0.7% 4.5  1.0% 90.0  3.6%
N 	 6 Peripheral blood 93.4  1.2% 96.5  0.4%
UC Gut-derived 94.8  5.6% 49.0  9.2%* 34.8  7.9%
N 	 8 Peripheral blood 90.1  2.6% 92.6  3.4%
CD Gut-derived 95.4  1.5% 27.7  6.6%* 59.7  8.1%
N 	 8 Peripheral blood 97.9  1.5% 86.4  4.2%
From patients with UC or CD and control patients, the gut-derived and peripheral blood lymphocyte, CD4 lymphocytes were gated. From this population, the
40% CD4CD45RBhigh and CD4CD45RBlow T cells were gated as described in Materials and Methods. In both subgroups, the percentages of CD45RA and
CD45RO expression were determined. Data are presented as mean and SE; * significant as compared with controls (P  0.05).
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cantly reduced in CD patients compared with normal controls.
In addition, the IFN- production of CD4CD45RBhigh cells of
UC patients was significantly decreased. There was a trend
toward higher production of IL-4 in CD patients (P	0.083),
whereas in UC patients, the IL-4 production was significantly
decreased (398.1 pg/ml116.2 in CD and 162.1 pg/ml78.8
in UC). No differences in TNF- production were found among
the three patient groups. The lymphocytes isolated from the gut
of UC and CD patients demonstrated an enhanced CD69,
CD134, CD44, and human leukocyte antigen-DR expression
compared with control lymphocytes (results not shown), indi-
cating an activated phenotype. This did not result in an en-
hanced, spontaneous cytokine secretion, as in the absence of
CD3 and CD28, these cells did not secrete detectable levels of
cytokines.
Cytokine profile of CD45RB gut-derived T cells
Cells were isolated from surgical resection specimen and
sorted for the expression of the CD4CD45RBhigh and
CD4CD45RBlow T cells. After sorting, the cells were stimu-
lated for 72 h by anti-CD3/anti-CD28 double-stimulation, and
the production of IFN-, IL-10, TNF-, and IL-4 was deter-
mined (Fig. 4). The results were similar to those found in
peripheral blood. CD4CD45RBlow T cells produced more
IL-10 and less TNF- as compared with the CD4CD45RBhigh
subgroup. CD4CD45RBhigh T cells isolated from a normal,
control patient produced very little. TNF- (CD4CD45RBlow
48.4 pg/ml and CD4CD45RBhigh 320.4 pg/ml in controls).
CD4CD45RBlow T cells from CD patients produced 504.0 
226.1 pg/ml and CD4CD45RBhigh 1933  1128 pg/ml. In
contrast to the low TNF- production, control-derived cells
produced high amounts of IL-10 compared with cells derived
from CD patients. Control CD4CD45RBlow T cells produced
691.3 pg/ml, as compared with 219.0  73.8 pg/ml in CD
patients. The CD4CD45RBhigh and CD4CD45RBlow sub-
groups produced similar amounts of IFN- (mean production in
CD: 50512002 pg/ml in CD45RBhigh and 44441419 pg/ml
in CD45RBlow).
DISCUSSION
Transfer of CD4CD45RBhigh expressing T lymphocytes into
an immunodeficient mouse induces severe intestinal inflam-
mation [2, 3], and cotransfer with lymphocytes expressing
CD4CD45RBlow T cells prevents disease development [4–6].
Because of this functional importance of CD45RB expression
in mouse intestinal inflammation, we studied the role of intes-
tinal CD4CD45RB T cell expression in patients with IBD. In
normal human mucosa, all CD4 T cells have the memory
Fig. 2. Confocal laser-scanning
microscopy of CD45RA (green) and
CD4 (red) in cryosections of intesti-
nal tissue of a CD patient. (A)
CD45RA/CD4 staining in follicular
structure. (B) CD45RA/CD4 stain-
ing in lamina propria. (C) Negative
control. Intense green cells are con-
sidered to be nonspecific. Original
magnification, 200.
Fig. 3. Cytokine production of peripheral blood cells
sorted for CD4CD45RBhigh (high) and CD4-
CD45RBlow (low) expression and subsequently stim-
ulated with CD3/CD28 for 72 h. (A) IL-10 production.
(B) IL-4 production. (C) TNF- production. (D) IFN-
production. Solid bars represent normal controls
(n	12); hatched bars represent CD patient (n	6);
and open bars represent UC patient (n	5). *, Signif-
icant difference (P0.05).
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phenotype CD45RO. We here report that in UC and CD, the
percentage of CD4CD45RBhigh CD45RA T cells is signifi-
cantly increased in the mucosal compartment. These
CD4CD45RA T cells were found mainly in the follicular
structures that are prominent in chronic inflammation.
The cytokine profile differs from CD45RBhigh and
CD45RBlow. The same profile was found in intestines and
peripheral blood, independent of CD45RA or CD45RO expres-
sion; thus, the level of CD45RB expression may be more
important than that of CD45RA or CD45RO.
In the peripheral blood of CD or UC patients and normal
controls, all CD4 CD45RBhigh T cells were CD45RA-posi-
tive, and CD4 CD45RBlow T cells were CD45RO-positive,
which is in agreement with previous reports [7, 8]. Analysis of
cells derived from the intestines revealed that in normal con-
trols, the majority of the CD45RBlow and CD45RBhigh cells of
control appeared to be memory cells (CD45RO). However, in
IBD patients, a significant part of the CD4CD45RBhigh T cells
were also CD45RA, and even a higher percentage was found
in UC compared with CD. Further studies will be needed to
elucidate the reason why and how these naı¨ve cells migrate to
the gut mucosa in IBD patients. The preferred presence of
memory cells in the gut observed in this study is in concor-
dance with the finding that T lymphocytes within the synovial
compartment of rheumatoid arthritis patients are almost exclu-
sively CD45RO [13].
CD45RBhigh cells switch to CD45RBlow within the tissue
[13, 15, 16], and when CD45RBhigh cells become CD45RBlow,
the capacity to produce IL-2 is significantly reduced. The
CD45RBlow cells will undergo apoptosis as a result of the loss
of IL-2 [17, 18]. This apoptotic process is mediated by a
gradual loss of Bcl-2 and gain of CD95 [9, 19]. One possible
explanation for the lower percentage of CD4CD45RBhigh T
cells in CD compared with UC is that the mechanism that
controls T lymphocyte activation and survival probably differs.
In CD, but not in UC, lamina propria T lymphocytes are less
sensitive to apoptosis as a result of a change in the Bax/Bcl-2
ratio [20, 21]. Our data suggest that this resistance to apoptosis
in CD is not caused by a defective switch from CD45RBhigh to
CD45RBlow and probably is a result of events further down-
stream.
Sorting experiments further emphasized the functional signifi-
cance of the CD45RBhigh and CD45RBlow expression in human
intestinal inflammation. Peripheral blood and intestinal T cells
were sorted for CD45RB expression, and subsequently, the cyto-
kine pattern was analyzed. In peripheral blood and intestinal
cells, different cytokine profiles were observed between
CD4CD45RBlow and CD4CD45RBhigh. CD4CD45RBlow
cells produce high amounts of IL-4 and IL-10, whereas the
CD4CD45RBhigh T cells produce high amounts of TNF-. The
markedly different cytokine profile of the CD45 subsets is remi-
niscent of analog mouse T lymphocyte subsets. In the mouse
transfer model of colitis, the CD45RBlow subset protects against
development of colitis, which is mediated by high production of
IL-10 [22]. We now demonstrate that human CD4CD45RBlow T
cells produce significantly more IL-10 than CD4CD45RBhigh T
cells. It is interesting that in our study, the CD4CD45RBlow
subset from IBD patients produced significantly less IL-10, which
has an immune-regulatory role in IBD. The pivotal importance of
IL-10 as a regulatory cytokine within the mucosal environment
was shown in IL-10/ mice, which develop severe colitis [23].
IL-10 was identified as a differentiation factor for a subset of T
lymphocytes, regulatory T lymphocytes (Tr1 cells). These Tr1
cells have immune-suppressive properties and were found to
suppress experimental colitis induced by transfer of pathogenic
CD4/CD45RBhigh T cells [24, 25]. The source of IL-10 important
for the development of regulatory T cells is not defined yet, but
special regulatory dendritic cell populations secreting high levels
of IL-10 could play a major role [26–28]. Future studies will
elucidate their role in IBD.
It is unexpected that CD4CD45RBlow T cells isolated from
UC patients produced low amounts of IL-4 compared with CD
patients and controls. However, it was previously reported that
IL-5 and not IL-4 plays an important role in UC [29]. Although
it was reported that CD45RBhigh cells produce more IFN-
[15], we did not observe differences in IFN- production
between CD45RB subsets obtained from controls. However,
the IFN- production by the CD4CD45RBhigh subset of IBD
patients was decreased. Furthermore, the role of IFN- in
intestinal inflammation is controversial, as IFN--deficient and
IFN- receptor-deficient mice are susceptible to experimental
2,4,6,-trinitrobenzene sulphonic acid-induced colitis [30, 31].
In summary, we here report marked differences in the ex-
pression of CD45RBhigh by T lymphocytes present in the
inflamed mucosa of patients with CD and UC. The CD45RBhigh
and CD45RBlow differentiation could be of clinical importance,
as we also observed an important, functional difference be-
tween both subgroups, not depending on CD45RA or CD45RO
expression. These results indicate that CD45RB could play an
important role in the maintenance of the intestinal inflamma-
tion by T cell activation.
Fig. 4. Cytokine production of gut-derived T cells sorted for
CD4CD45RBhigh (H) and CD4CD45RBlow (L) expression and subsequently
stimulated with CD3/CD28 for 72 h. (A) IL-10 production. (B) IL-4 production.
(C) TNF- production. (D) IFN- production. Solid bars represent a normal
control; hatched bars represent CD patients.
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